Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jitesh Doshi

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Bioinformation|June 3, 2022
Molecular docking analysis of arjunolic acid from <i>Terminalia arjuna</i> with a coronary artery disease target APOE4Lima Hazarika, Supriyo Sen, Jitesh Doshi
The Journal of Physical Chemistry. B|December 29, 2021
Elevated Fibrinogen Level Reduces Therapeutic Efficiency of AD Drugs: Biophysical Insights into the Interaction of FDA-Approved Cholinesterase Inhibitors with Human FibrinogenPrayasee Baruah, Debojit Paul, Jitesh Doshi, et al.
BMC Bioinformatics|April 28, 2018
PDZscape: a comprehensive PDZ-protein databaseJitesh Doshi, Raja Reddy Kuppili, Siddharth Gurdasani, et al.
ACS Omega|December 11, 2023
Synthesis and Evaluation of Ivacaftor Derivatives with Reduced LipophilicityMelissa Iazzi, Phillip Junor, Jitesh Doshi, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Bioinformation|June 3, 2022
Molecular docking analysis of arjunolic acid from <i>Terminalia arjuna</i> with a coronary artery disease target APOE4Lima Hazarika, Supriyo Sen, Jitesh Doshi
The Journal of Physical Chemistry. B|December 29, 2021
Elevated Fibrinogen Level Reduces Therapeutic Efficiency of AD Drugs: Biophysical Insights into the Interaction of FDA-Approved Cholinesterase Inhibitors with Human FibrinogenPrayasee Baruah, Debojit Paul, Jitesh Doshi, et al.
BMC Bioinformatics|April 28, 2018
PDZscape: a comprehensive PDZ-protein databaseJitesh Doshi, Raja Reddy Kuppili, Siddharth Gurdasani, et al.
ACS Omega|December 11, 2023
Synthesis and Evaluation of Ivacaftor Derivatives with Reduced LipophilicityMelissa Iazzi, Phillip Junor, Jitesh Doshi, et al.
Pageof 1